Bill > A4391

Introduced Session

This bill allows pharmacists to transfer Schedule II controlled dangerous substance prescriptions for attention-deficit/hyperactivity disorder to other pharmacists. Specifically, the bill provides that a Schedule II controlled dangerous substance that is prescribed for attention-deficit/hyperactivity disorder may be transferred from a pharmacist to another pharmacist, provided the prescription transfer is in compliance with federal regulations. Federal rules recently changed to allow the transfer of Schedule II-V controlled dangerous substance prescriptions between licensed pharmacies for the initial filling on a one-time basis only, upon request from the patient. New Jersey currently allows for transfers of Schedule III-V controlled dangerous substance prescriptions; this bill would expand allowable transfers to also include Schedule II controlled dangerous substance prescriptions. The bill will allow for greater flexibility for people attempting to fill attention-deficit/hyperactivity disorder prescriptions. The ability to easily transfer prescriptions between pharmacies is especially valuable to patients who are attempting to fill prescriptions for medicine that is less available due to a shortage. Currently, when a patient is unable to fill a prescription at a particular pharmacy, the patient must ask their health care provider to send a new prescription to a different pharmacy. The bill will allow for a more efficient transfer process, by allowing pharmacies to directly transfer attention-deficit/hyperactivity disorder prescriptions.

AI Summary

Committee Categories

Margie Donlon (D)*,  Andrea Katz (D)*,  Sterley Stanley (D)*,  Rosaura Bagolie (D),  Herbert Conaway (D),  Dan Hutchison (D),  Carol Murphy (D),  William Sampson (D),  Shanique Speight (D),  Chris Tully (D), 

Substituted by S3388 (on 02/27/2025)

Official Document